Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
- DOI
- 10.15585/mmwr.mm7113e2
- Published
- 2022 Apr 1
- Container
- MMWR. Morbidity and mortality weekly report
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.15585/mmwr.mm7113e2,
title = {Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson \& Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.},
author = {Natarajan K and Prasad N and Dascomb K and Irving SA and Yang DH and Gaglani M and Klein NP and DeSilva MB and Ong TC and Grannis SJ and Stenehjem E and Link-Gelles R and Rowley EA and Naleway AL and Han J and Raiyani C and Benitez GV and Rao S and Lewis N and Fadel WF and Grisel N and Griggs EP and Dunne MM and Stockwell MS and Mamawala M and McEvoy C and Barron MA and Goddard K and Valvi NR and Arndorfer J and Patel P and Mitchell PK and Smith M and Kharbanda AB and Fireman B and Embi PJ and Dickerson M and Davis JM and Zerbo O and Dalton AF and Wondimu MH and Azziz-Baumgartner E and Bozio CH and Reynolds S and Ferdinands J and Williams J and Schrag SJ and Verani JR and Ball S and Thompson MG and Dixon BE},
year = {2022},
journal = {MMWR. Morbidity and mortality weekly report},
doi = {10.15585/mmwr.mm7113e2},
url = {https://doi.org/10.15585/mmwr.mm7113e2}
}RIS
TY - JOUR TI - Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022. AU - Natarajan K AU - Prasad N AU - Dascomb K AU - Irving SA AU - Yang DH AU - Gaglani M AU - Klein NP AU - DeSilva MB AU - Ong TC AU - Grannis SJ AU - Stenehjem E AU - Link-Gelles R AU - Rowley EA AU - Naleway AL AU - Han J AU - Raiyani C AU - Benitez GV AU - Rao S AU - Lewis N AU - Fadel WF AU - Grisel N AU - Griggs EP AU - Dunne MM AU - Stockwell MS AU - Mamawala M AU - McEvoy C AU - Barron MA AU - Goddard K AU - Valvi NR AU - Arndorfer J AU - Patel P AU - Mitchell PK AU - Smith M AU - Kharbanda AB AU - Fireman B AU - Embi PJ AU - Dickerson M AU - Davis JM AU - Zerbo O AU - Dalton AF AU - Wondimu MH AU - Azziz-Baumgartner E AU - Bozio CH AU - Reynolds S AU - Ferdinands J AU - Williams J AU - Schrag SJ AU - Verani JR AU - Ball S AU - Thompson MG AU - Dixon BE PY - 2022 JO - MMWR. Morbidity and mortality weekly report DO - 10.15585/mmwr.mm7113e2 UR - https://doi.org/10.15585/mmwr.mm7113e2 ER -
APA
K, N., N, P., K, D., SA, I., DH, Y., M, G., NP, K., MB, D., TC, O., SJ, G., E, S., R, L., EA, R., AL, N., J, H., C, R., GV, B., S, R., N, L., WF, F., N, G., EP, G., MM, D., MS, S., M, M., C, M., MA, B., K, G., NR, V., J, A., P, P., PK, M., M, S., AB, K., B, F., PJ, E., M, D., JM, D., O, Z., AF, D., MH, W., E, A., CH, B., S, R., J, F., J, W., SJ, S., JR, V., S, B., MG, T., & BE, D. (2022). Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.. MMWR. Morbidity and mortality weekly report. https://doi.org/10.15585/mmwr.mm7113e2
Source records
- pubmed · retrieved 2026-09-26T06:07:49.815Z